More CREDENCE for SGLT2 Inhibition

被引：14
作者：
Verma, Subodh [1 ]
Bhatt, Deepak L. [2 ]
机构：
[1] Univ Toronto, St Michaels Hosp, Div Cardiac Surg, 8th Floor,Bond Wing,30 Bond St, Toronto, ON M5B 1W8, Canada
[2] Harvard Med Sch, Brigham & Womens Hosp, Heart & Vasc Ctr, Boston, MA 02115 USA
来源：
CIRCULATION | 2019年 / 140卷 / 18期
关键词：
cardiovascular diseases; diabetes mellitus; diabetic nephropathies; kidney failure; chronic;
D O I：
10.1161/CIRCULATIONAHA.119.041181
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1448 / 1450
页数：3
相关论文
共 50 条
[31]   Cardiovascular benefit of SGLT2 inhibitors [J].
Mohebi, Reza ;
Januzzi, James L. .
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2022, 59 (03) :142-155
[32]   SGLT2 Inhibitors and Their Antiarrhythmic Properties [J].
Kolesnik, Ewald ;
Scherr, Daniel ;
Rohrer, Ursula ;
Benedikt, Martin ;
Manninger, Martin ;
Sourij, Harald ;
von Lewinski, Dirk .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
[33]   SGLT2 Inhibitors in Liver Patients [J].
Hsiang, John Chen ;
Wong, Vincent Wai-Sun .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (10) :2168-+
[34]   Unmasking a sustained negative effect of SGLT2 inhibition on body fluid volume in the rat [J].
Masuda, Takahiro ;
Watanabe, Yuko ;
Fukuda, Keiko ;
Watanabe, Minami ;
Onishi, Akira ;
Ohara, Ken ;
Imai, Toshimi ;
Koepsell, Hermann ;
Muto, Shigeaki ;
Vallon, Volker ;
Nagata, Daisuke .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2018, 315 (03) :F653-F664
[35]   Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition [J].
Vallon, Volker ;
Thomson, Scott C. .
DIABETOLOGIA, 2017, 60 (02) :215-225
[36]   SGLT2 Inhibition, Choline Metabolites, and Cardiometabolic Diseases: A Mediation Mendelian Randomization Study [J].
Xu, Min ;
Zheng, Jie ;
Hou, Tianzhichao ;
Lin, Hong ;
Wang, Tiange ;
Wang, Shuangyuan ;
Lu, Jieli ;
Zhao, Zhiyun ;
Li, Mian ;
Xu, Yu ;
Ning, Guang ;
Bi, Yufang ;
Wang, Weiqing .
DIABETES CARE, 2022, 45 (11) :2718-2728
[37]   Emergence of SGLT2 Inhibitors as Powerful Antioxidants in Human Diseases [J].
Tsai, Kai-Fan ;
Chen, Yung-Lung ;
Chiou, Terry Ting-Yu ;
Chu, Tian-Huei ;
Li, Lung-Chih ;
Ng, Hwee-Yeong ;
Lee, Wen-Chin ;
Lee, Chien-Te .
ANTIOXIDANTS, 2021, 10 (08)
[38]   Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus [J].
Mahling, Moritz ;
Schork, Anja ;
Nadalin, Silvio ;
Fritsche, Andreas ;
Heyne, Nils ;
Guthoff, Martina .
KIDNEY & BLOOD PRESSURE RESEARCH, 2019, 44 (05) :984-992
[39]   SGLT1 and SGLT2 inhibition, circulating metabolites, and cerebral small vessel disease: a mediation Mendelian Randomization study [J].
Lv, Yanchen ;
Cheng, Xin ;
Dong, Qiang .
CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
[40]   SGLT2 Inhibitors and Heart Failure Outcomes [J].
Chim, Christine ;
Newaz, Shahreear .
US PHARMACIST, 2020, 45 (02) :18-22
12345